Home > Income Statement > MANKIND PHARMA

MANKIND PHARMA
Revenue

    Back to Income Statement
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Revenue History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Net Sales ₹8,749 Cr₹7,782 Cr₹621 Cr₹58,719 Cr₹4,980 Cr

What is the latest Revenue of MANKIND PHARMA ?

The latest Revenue ratio of MANKIND PHARMA is ₹8,749 Cr based on Mar2024 Consolidated results.
Year Revenue
Mar2024₹8,749 Cr
Mar2023₹7,782 Cr
Mar2022₹621 Cr
Mar2021₹58,719 Cr
Mar2020₹4,980 Cr

How is Revenue of MANKIND PHARMA Trending?

Years Revenue % Change
Mar2024 ₹8,749 Cr
12.44
Mar2023 ₹7,782 Cr
1,152.18
Mar2022 ₹621 Cr
-98.94
Mar2021 ₹58,719 Cr
1,079.10
Mar2020 ₹4,980 Cr -

Compare Revenue of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹102,240.6 Cr -2.1% -0.6% 33.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹431,352.0 Cr 1.7% -4.7% 48.8% Stock Analytics
DIVIS LABORATORIES ₹159,265.0 Cr 4.4% 3.1% 66% Stock Analytics
CIPLA ₹120,035.0 Cr -0.9% -1.7% 17.3% Stock Analytics
DR REDDYS LABORATORIES ₹101,286.0 Cr -1% -8.9% 6.5% Stock Analytics
ZYDUS LIFESCIENCES ₹95,461.4 Cr -1% -4% 48.4% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-2.1%

-0.6%

33.1%

SENSEX

-1.9%

-5%

17.5%


You may also like the below Video Courses